ATNEC: A multicenter, randomized trial investigating whether axillary treatment can be avoided in patients with T1-3N1M0 breast cancer with no residual cancer in the lymph glands after neoadjuvant chemotherapy.

Amit Goyal, Sophie Cramp,Andrea Marshall,Natalie Hammonds,Duncan Wheatley,Beatrix Elsberger, Shama Puri,Tara Homer,Luke Vale, Roeum Butt, Zohal Nabi, Janice Rose, Helen Teresa Edwards,Samreen Ahmed,Abeer Shaaban,Julie Bruce, Sophie Gasson,Helen Higgins,Janet Dunn

JOURNAL OF CLINICAL ONCOLOGY(2022)

引用 0|浏览7
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要